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Conclusions: HNa occurs frequently dunng the acute phase of STEMI and is a strong 
NSTSE (n=47) STSE (n=21) IL6 levels (pg/ml) Independent predictor of increased short-term mortality. 
IL6 gene polymorphism 53% 
G/G (n=31) 43% 
G/C (n=30) 4.3% 
c/c (n=7) 
27% 3.2 * 2.9 
47% 7.2 * 9.9 
24% 13.1 * 15.4 
P value 0.025 (&#61539;2) 0.049 (Kr-Wallis) 
1048-95 C-Reactive Protein Levels as an Early Predictor of 30. 
Day Mortality in Patients With Acute Myocardial 
infarction 
Mahmoud A. Suleiman, Doron Aronson. Michael Kapeliovich. Arthour Kerner. Yishai 
Levy, Haim Hammenan, Rambam Medical Center, Haifa, Israel, Technion Faculty of 
Medicine, Haifa, Israel 
Background: In patients with unstable angina, elevated C-reactive protein (CRP) has 
been shown to predict recurrent coronary events. However, little data is available on the 
prognostic value of CRP in acute myocardial infarction (AMI), and its relation to mea- 
sures of infarct size. 
Methods: CRP was measured within 24-h of symptoms onset in a prospective series of 
348 consecutive patients (mean age 62 + 13 y, men - 76%) with AMI (260 with ST-eleva- 
tion AMI). Echocardiographic examination was performed on day 2 or 3. Thirty-day mor- 
tality was evaluated using Cox proportional-hazards model wtth the following covariates: 
age, gender, prior aspirin use, Killip class, diabetes, peak CK. SBP < 100 mm Hg, 
echocardiographic wall motion score index (WMSI). and repelfusion therapy (primary 
angioplasty or thrombolytic therapy). 
Results: Patients with CRP levels in the upper tertile (>2.2 mg/UL) had higher peak CK 
(1999 t 166 vs 1762 * 116, p = 0.01) and higher echocardiographic wall motion score 
index (1.6 * 0.4 vs 1.5 + 0.4, p < 0.0001). Kaplan-Meier surwal wives indicated that 
patients with CRP levels in the upper tertile were at Increased risk of 30.day mortality 
(Figure). In a Cox’s multivariate analysis, CRP level in the upper tertile was a significant 
and independent predictor of 30-day mortality (Relative Risk = 3.2, 95% Cl 1.2-6.2, p = 
0.007). 
Conclusion: CRP level on admission is a powerful predictor of 30-day mortality in 
patients with AMI independent of infarct size and other traditional predictors of outcome. 
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1048-96 Hyponatremia Is a Powerful Independent Predictor of 
Short-Term Mortality In Patients With Acute ST 
Elevation Myocardial Infarction 
Alexander Goldberq, Haim Hammerman, Sirouch Petcherski, Elena Koifman, Alexander 
Zdorovyak, Michael Kapeliovich, Walter Markiewicz, Doron Aronson. Rambam Medical 
Center, Haifa. Israel 
Background: Hyponatremia (HNa) is recognized as a predictor of adverse outcome in 
hospitalized patients (pts), especially in pts with heart failure. However, little is known 
about the prevalence and prognostic significance of HNa in pts with acute ST-elevation 
myocardial infarctjon (STEMI). 
Methods: We studied 706 consecutive pts (age 62 f 13, 75% male) with STEMI. Plasma 
sodium (Na) was measured on admission and at 24,46, and 72 hours thereafter. go-day 
mortality was evaluated using Cox proportional-hazards model, adjusting for important 
covariates including age, gender, diabetes, Killip class, peak CK, diuretic therapy, reper- 
fusion therapy (thrombolysis or primary angioplasty), ejection fraction, heart rate > 100, 
and svstolic blood oressure < 100 mm Ha on admission. 
Rest&: HNa (N&l35 mmol/L) developed during the first 72-h of hospital stay in 53% 
of Dts. Na decreased to 126.130 mmol/L in 29 ots and to<125 mmollL in 7 ots. Althouoh 
pti receiving diuretics developed HNa more commonly compared to pts who were not 
(64% vs. 46%, p < O.OOOl), the majority of pts (66%) who developed HNa were not 
receiving diuretics. Kaplan-Meyer survival curves indicated that pts who developed HNa 
were at increased risk of go-day mortality (Figure). In a Cox multivariate analysis, HNa 
remained a significant and independent predictor of go-day mortality (RR 3.0, 95% Cl 
1.3-6.5, p = 0.006). 
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1048-97 lschemia Modified Albumin: A New Biomarker of 
Myocardial lschemia for Early Diagnosis of Acute 
Coronary Syndromes 
Michael C. Kontos, Steven Schorer, James D. Kirk, Dana R. Fletcher, Debra L. Morris, 
Virginia Commonwealth University/Medical College of Virginia, Richmond, VA, Mercy 
Healthcare, Sacramento, CA 
Background: Chest paln is one of the most common reasons for emergency department 
(ED) visits in the US, accounting for about 6% of all visits. Identifying the etiology of chest 
pain is challenging and resource-intensive. Although Ml can be diagnosed using sensi- 
tive cardiac injury markers, currently no such marker is available for diagnosing 
ischemia. ED diagnosis is based on the physician’s clinical judgment using findings from 
the history, clinical exam, and diagnostic tests including the ECG and rest myocardial 
perfusion imaging (MPI). However, idenhfication is limited by the sub-optimal sensibvity 
of the ECG. Although MPI has higher sensitivity and negative predictive value (NPV), it is 
not wdely used due to its cost and complexity. lschemla Modified Albumin (IMATM) is 
produced when circulating albumin comes in contact with ischemic myocardium. IMA 
increases with ischemia and is detectable in serum prior to necrosis markers. IMA utility 
and diagnostic accuracy compared to traditional methods for diagnosing myocardial 
ischemia in the ED has not been well described. Methods: We are currently enrolling 
patients (pts)(target = 400) presenting to the ED with acute chest pain. Pts undergo rest 
MPI with either ongoing symptoms or within 1 hour of pain cessation. The ED ECG is 
recorded and serial sampling of IMA before and after rest MPI is performed. Diagnosis of 
ischemia is determined by expert cardiologists blinded to IMA values using all clinical 
data collected at presentation and during routine follow-up. Results: Data from the first 
127 patents was available for analysis; 54 males, 73 females; mean age 52 years (30- 
96). Final diagnosis was 14 positive and 113 negative for &hernia. Sensitivity of IMA 
(cutoff 85 UlmL), ECG, and MPI for ischemia was 71%, 21%, and 69%, respectively. 
NPV of IMA, ECG, and MPI was 90%, 91%, and 96%, respectively. Adding the ECG to 
IMA did not improve sensitivity over IMA alone, but combining results from IMA and MPI 
produced a sensitivity and NPV of 100% Conclusions: These preliminary results sug- 
gest that IMA improves the ability to diagnose myocardial &hernia in pts presenting to 
the ED with acute chest pain. 
1048-98 Early Detection of Myocardial lschemia by a Novel 
Blood-Based Biomarker: The Kinetics of lschemia 
Modified Albumin 
ChrlstoDher deFiliDDi, Samual Yoon, Christian Bounds, Linda Romar. Alexander Ro, 
William Herzog, Lawrence Stafford, Robert H. Christenson, University of Maryland, 
Baltimore, MD 
Background: Quantifying subtle myocardial injury IS now routine, however, early detec- 
tion of myocardial &hernia using serum biomarkers remains elusive. lschemia modified 
albumin@ (IMA) is a promising new blood test for detection of ischemia. We studied IMA 
in the setting of percutaneous coronary intervention (PCI) as a model of known transient 
ischemla. 
Methods: Eleven patients (pts) (age 60+1 I, 7 males) without evidence of ischemia for > 
7 days undergoing single-vessel PCI (6 RCA and 3 LAD) were enrolled. Blood was col- 
lected: pre-PCI after arterial access, <IO minutes post initial balloon inflation (post-lnfl), 
and 2.6, 9, 12. 16 hours (hr) post-PCI. Samples were tested for IMA, troponin T and CK- 
MB. 
Results: All patients had successful PCI, with mean longest and total balloon inflation 
times of 2.5+1 .I and 4.321.9 minutes, respectively. Pre-PCI mean IMA levels (95.4*7.2 
UlmL) increased in IO of 11 pts post-lnfl (104.9ilO.9 UlmL. P<O.OOl versus pre-PCI) 
(Figure). IMA levels post-PC1 at 2 hr (97.6+11.4 U/mL), 6 hr (91.0+12.2 UlmL), 9 hr, 12 hr 
and 16 hr were not significantly different from pre-PCI. Seven patients had ECG or 
echocardiographic evidence of ischemia with PCI, while 2 had post-PC1 injury measured 
by troponin T or CK-MB. 
